Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
48,289,798
-
Share change
-
-852,890
-
Total reported value
-
$1,864,900,092
-
Put/Call ratio
-
349%
-
Price per share
-
$38.61
-
Number of holders
-
264
-
Value change
-
-$48,609,469
-
Number of buys
-
135
-
Number of sells
-
120
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2022
As of 31 Dec 2022,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,289,798 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, MACQUARIE GROUP LTD, ARMISTICE CAPITAL, LLC, BAILLIE GIFFORD & CO, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, LOOMIS SAYLES & CO L P, Invesco Ltd., and Stephens Investment Management Group LLC.
This page lists
267
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.